Btk inhibitors in atherosclerosis

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.

Original languageEnglish (US)
Pages (from-to)2601-2602
Number of pages2
JournalBlood
Volume131
Issue number24
DOIs
StatePublished - Jun 14 2018
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Btk inhibitors in atherosclerosis'. Together they form a unique fingerprint.

Cite this